Lineage Cell Therapeutics (LCTX) Insider Trading & Ownership $0.47 +0.00 (+0.42%) As of 01:43 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage23.60%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$43,845.00Number OfInsiders Selling(Last 12 Months)0 Get LCTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Lineage Cell Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LCTX Insider Buying and Selling by Quarter Lineage Cell Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/21/2024Brian M CulleyCEOBuy40,000$0.60$24,000.00 8/16/2024Jill Ann HoweCFOBuy10,500$0.89$9,345.00 5/24/2024Brian M CulleyCEOBuy10,000$1.05$10,500.00 (Data available from 1/1/2013 forward) LCTX Insider Trading Activity - Frequently Asked Questions Who is on Lineage Cell Therapeutics's Insider Roster? The list of insiders at Lineage Cell Therapeutics includes Brian M Culley, Broadwood Partners, L.P., Don M Bailey, and Jill Ann Howe. Learn more on insiders at LCTX. What percentage of Lineage Cell Therapeutics stock is owned by insiders? 23.60% of Lineage Cell Therapeutics stock is owned by insiders. Learn more on LCTX's insider holdings. Which Lineage Cell Therapeutics insiders have been buying company stock? The following insiders have purchased LCTX shares in the last 24 months: Brian M Culley ($34,500.00), Broadwood Partners, L.P. ($7,000,000.80), Don M Bailey ($100,001.20), and Jill Ann Howe ($9,345.00). How much insider buying is happening at Lineage Cell Therapeutics? Insiders have purchased a total of 6,887,425 LCTX shares in the last 24 months for a total of $7,143,847.00 bought. Lineage Cell Therapeutics Key ExecutivesMr. Brian M. Culley M.A. (Age 53)M.B.A., CEO, President & Director Compensation: $986.7k1 recent tradesMs. Jill Ann Howe (Age 47)CFO & Principal Financial and Accounting Officer Compensation: $587.4kMr. George A. Samuel III (Age 43)J.D., General Counsel & Company Secretary Compensation: $554.51kIoana C. HoneDirector of Investor RelationsDr. Charlotte Hubbert Ph.D.Vice President of Corporate DevelopmentMs. Brandi L. Roberts CPA (Age 50)M.B.A., Consultant Compensation: $407.45kMr. William Annett MBA (Age 70)President & CEO of OncoCyte Corporation Compensation: $53.2kDr. Rami Skaliter Ph.D. (Age 66)Chief Executive Officer of Cell Cure Neurosciences Ms. Alexandra HernandezSenior Director of Finance & ControllerDr. Harold D. Waitz (Age 82)Vice President of Regulatory Affairs & Quality Control Compensation: $90k More Insider Trading Tools from MarketBeat Related Companies ERAS Insider Transactions ORKA Insider Transactions ORIC Insider Transactions CKPT Insider Transactions TECX Insider Transactions RGNX Insider Transactions OLMA Insider Transactions BNTC Insider Transactions CMPS Insider Transactions TKNO Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Buying in This Stock Reiterates Analysts Bullish OutlookBeware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market Sentiment This page (NYSEAMERICAN:LCTX) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Collapse Is Already HereWhen a system is about to fail, those trained to spot it often notice before anyone else. Tim Plaehn flew high...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lineage Cell Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lineage Cell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LCTX Stock Free LCTX Stock Alerts